Bluebird bio Inc (NASDAQ: BLUE) May Be Attracting Institutional Investments

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

Bluebird bio Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Bluebird bio Inc is $81.77M. A total of 0.77 million shares were traded on the day, compared to an average of 407.64K shares.

In the most recent transaction, Obenshain Andrew sold 971 shares of BLUE for 0.42 per share on Dec 10 ’24. After the transaction, the President and CEO now owns 374,247 company shares. In a previous transaction on Dec 10 ’24, Colvin Richard A sold 2,824 shares at 0.42 per share. BLUE shares that Chief Medical Officer owns now total 165,544.

Among the insiders who bought shares, Colvin Richard A acquired of 2,824 shares on Dec 10 ’24 at a per-share price of $0.45. In another insider transaction, Obenshain Andrew bought 971 shares at $0.45 per share on Dec 10 ’24.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, BLUE has a high of $64.00 and a low of $5.80.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BLUE’s latest balance sheet shows that the firm has $299.50M in Cash & Short Term Investments as of fiscal 2021. There were $89.58M in debt and $152.99M in liabilities at the time. Its Book Value Per Share was -$0.60, while its Total Shareholder’s Equity was $374.28M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BLUE is Buy with a score of 3.00.

Most Popular

Related Posts